GlassScriptPhysician profile
Ida M Lim
NPI 1013409051
$1,372.42
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $1,260.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $548.62 | 2021-2022 | |
| Treace Medical Concepts, INC. | $305.99 | 2022 | |
| Horizon Therapeutics Plc | $112.41 | 2022 | |
| Nevro Corp. | $87.62 | 2022 | |
| Smith+Nephew, INC. | $59.71 | 2021-2022 | |
| Trimed, INC. | $50.78 | 2022 | |
| Bioventus LLC | $40.19 | 2022 | |
| Convatec INC. | $36.97 | 2022 | |
| Organogenesis INC. | $27.59 | 2022 | |
| Tactile Systems Technology INC | $25.12 | 2022 | |
| Paratek Pharmaceuticals, INC. | $24.59 | 2022 | |
| Ibsa Pharma INC. | $19.88 | 2021 | |
| Triad Life Sciences INC. | $18.44 | 2022 | |
| Hartmann USA, INC. | $14.51 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ida Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.